5 years ago

Sano Genetics Secures £2.5M to Advance Personalized Medicine Research

  • Cambridge-based startup Sano Genetics has raised £2.5 million in a seed funding round led by Episode1 Ventures, with participation from Cambridge Enterprise, Seedcamp, January Venture, and angel investors

  • The funding will be used to accelerate research into Long Covid, further develop their tech platform, and provide free at-home DNA testing kits

  • Sano Genetics partners with Genomics England to develop software for national-scale precision medicine initiatives.

      • ProblemHealthcare

      "Clinical trials have a high failure rate and participants have a poor experience. This is due to a lack of access to diverse and representative patient populations."

      Solution

      "Sano Genetics provides a digital platform and at-home genetic testing capabilities that empower greater participation in clinical trials. The platform gives users full control and transparency over their data, and the at-home testing kits make it easier for people to participate in research."

      Covered on